Treprostinil is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Treprostinil.
| Product ID | 62332-515_640d13cf-e774-4d34-8c81-3410f9724130 |
| NDC | 62332-515 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Treprostinil |
| Generic Name | Treprostinil |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2021-02-11 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211574 |
| Labeler Name | Alembic Pharmaceuticals Inc. |
| Substance Name | TREPROSTINIL |
| Active Ingredient Strength | 50 mg/20mL |
| Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-02-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0703-0666 | Treprostinil | Treprostinil |
| 0703-0676 | Treprostinil | Treprostinil |
| 0703-0686 | Treprostinil | Treprostinil |
| 0703-0696 | Treprostinil | Treprostinil |
| 0781-3420 | Treprostinil | treprostinil |
| 0781-3425 | Treprostinil | treprostinil |
| 0781-3427 | Treprostinil | treprostinil |
| 0781-3430 | Treprostinil | treprostinil |
| 42023-206 | Treprostinil | Treprostinil |
| 42023-207 | Treprostinil | Treprostinil |
| 42023-208 | Treprostinil | Treprostinil |
| 42023-209 | Treprostinil | Treprostinil |
| 62332-514 | Treprostinil | Treprostinil |
| 62332-515 | Treprostinil | Treprostinil |
| 62332-516 | Treprostinil | Treprostinil |
| 62332-517 | Treprostinil | Treprostinil |
| 66302-300 | Orenitram | treprostinil |
| 66302-101 | Remodulin | treprostinil |
| 66302-102 | Remodulin | treprostinil |
| 66302-105 | Remodulin | treprostinil |
| 66302-110 | Remodulin | treprostinil |
| 66302-206 | TYVASO | treprostinil |